NCT06485206View on ClinicalTrials.gov

Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.

NARecruitingINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
Degenerative Disc Disease
Interventions
DEVICE

One level Mobi-C and one level fusion

"Cervical Disc Arthroplasty:~• Mobi-C~Fusion devices:~* One-level cervical plates~ o MaxAn Cervical plate system~* Interbody spacers~ * TrellOss-C - 3D printed Ti interbody~ * Vista-S - PEEK interbody~* Standalone Fixation~ * Ti-Coated ROI-C - PEEK cage w/ Ti coating~ * TrellOss-C SA - 3D printed Ti~* Bone Graft~ * Local Autograft~ * PrimaGen Advanced Allograft"

Trial Locations (2)

48033

RECRUITING

Michigan Orthopaedic Surgeons, Southfield

95816

RECRUITING

University of California-Davis, Sacramento

Sponsors

Lead Sponsor

Highridge Medical
All Listed Sponsors
lead

Highridge Medical

INDUSTRY

NCT06485206 - Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine. | Biotech Hunter | Biotech Hunter